Suraj Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.80 Cr
- Revenue Growth -2.84%
- Profit Growth -8.66%
- Ebitda 62.34%
- Net Worth 3035.79%
- Total Assets 22.35%
About Suraj Biotech
Suraj Biotech Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 July 2009 and has a history of 15 years and six months. Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹7.80 Cr.
Shivpratapsingh Kushwah and Taral Shah serve as directors at the Company.
Company Details
-
Location
Gandhi Nagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01400GJ2009PTC057609
-
Company No.
057609
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Suraj Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivpratapsingh Kushwah
|
Director | 10-Mar-2021 | Current |
| Taral Shah | Director | 17-Aug-2024 | Current |
Financial Performance of Suraj Biotech.
Suraj Biotech Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.84% decrease. The company also saw a slight decrease in profitability, with a 8.66% decrease in profit. The company's net worth Soared by an impressive increase of 3035.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suraj Biotech?
In 2021, Suraj Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Neptune Enterprise Private LimitedShivpratapsingh Kushwah is a mutual person
-
Suraj Cropsciences LimitedShivpratapsingh Kushwah is a mutual person
-
Vigour Seeds Private LimitedShivpratapsingh Kushwah is a mutual person
Charges (Loans)
₹7.80 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 7.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2019 | State Bank Of India | ₹7.80 Cr | Open |
How Many Employees Work at Suraj Biotech?
Unlock and access historical data on people associated with Suraj Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suraj Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suraj Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
